Document is current
Any future updates will be listed below
-
Authors
Theuring, Stefanie
Kern, Mascha
Hommes, Franziska
Mall, Marcus A.
Seybold, Joachim
Mockenhaupt, Frank P.
Glatz, Toivo
Kurth, Tobias
-
Funding
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 23 September 2022
Accepted: 27 December 2022
First Online: 3 January 2023
Change Date: 6 February 2023
Change Type: Update
Change Details: The dagger symbol in the author group has been corrected.
Declarations
:
: All participants or their legal guardians gave written informed consent upon inclusion into the study. The ethics committee of Charité—Universitätsmedizin Berlin reviewed the study protocol (Protocol number EA2/091/20).
: Not applicable.
: None of the authors had a conflict of interest directly related to the content of the study. Outside the work, TK reports to have received research grants from the Gemeinsamer Bundesausschuss (G-BA, Federal Joint Committee, Germany), the Bundesministerium für Gesundheit (BMG, Federal Ministry of Health, Germany). He further has received personal compensation from Eli Lilly and Company, Teva Pharmaceuticals, TotalEnergies S.E., The BMJ, and Frontiers. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
